View Categories

Lymphoid Structure

22 min read

Introduction #

The lymphoid system represents a sophisticated network of organs, tissues, and cells that orchestrates immune surveillance and adaptive immune responses throughout the body. Understanding lymphoid structure is fundamental to comprehending immune function, immunodeficiency disorders, autoimmune diseases, and the pathophysiology of lymphoproliferative disorders. This review synthesizes current knowledge of lymphoid anatomy, histology, cellular organization, and clinical correlations relevant to medical education and clinical practice.

Primary Lymphoid Organs #

Thymus

The thymus serves as the primary site of T lymphocyte maturation and is essential for establishing central tolerance. Located in the anterior superior mediastinum, the thymus is most active during childhood and undergoes progressive involution after puberty, with fatty replacement of lymphoid tissue continuing throughout adulthood [1].

Anatomical Structure and Histology

The thymus is organized into distinct cortical and medullary regions, each with specialized functions in T cell development. The cortex appears densely populated with immature T lymphocytes (thymocytes) and contains cortical epithelial cells that express both major histocompatibility complex (MHC) class I and class II molecules [2]. The medulla contains mature T cells, medullary epithelial cells, dendritic cells, and characteristic Hassall’s corpuscles, which are concentrically arranged epithelial cells thought to contribute to regulatory T cell development [3].

The blood-thymus barrier, formed by capillary endothelial cells, basement membrane, and epithelial cells, protects developing thymocytes from circulating antigens, preventing premature activation and maintaining the proper environment for tolerance induction [4].

T Cell Development and Selection

Thymocyte maturation proceeds through distinct stages characterized by CD4 and CD8 expression patterns. Bone marrow-derived progenitors enter the thymus as double-negative cells (CD4⁻CD8⁻), progress to double-positive cells (CD4⁺CD8⁺) in the cortex, and ultimately differentiate into single-positive cells (CD4⁺ or CD8⁺) following successful selection [5].

Positive selection occurs in the thymic cortex, where thymocytes with T cell receptors (TCRs) capable of recognizing self-MHC molecules receive survival signals from cortical epithelial cells. Cells failing positive selection undergo apoptosis by neglect [6]. Negative selection eliminates thymocytes with high-affinity binding to self-antigens presented on MHC molecules, primarily occurring at the corticomedullary junction and medulla through interactions with medullary epithelial cells and dendritic cells [7].

The autoimmune regulator (AIRE) protein, expressed in medullary epithelial cells, enables promiscuous expression of tissue-restricted antigens, facilitating deletion of autoreactive T cells and preventing autoimmunity [8]. Mutations in the AIRE gene cause autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), demonstrating the critical role of central tolerance [9].

Clinical Correlations

DiGeorge syndrome, resulting from 22q11.2 deletion, leads to thymic aplasia or hypoplasia, causing T cell immunodeficiency with resultant susceptibility to viral, fungal, and intracellular bacterial infections [10]. Thymomas and thymic carcinomas may be associated with myasthenia gravis due to aberrant immune responses [11].

Bone Marrow

The bone marrow functions as the primary site of hematopoiesis and B lymphocyte development in postnatal life. Additionally, the bone marrow provides a microenvironment for long-lived plasma cells that maintain humoral immunity [12].

B Cell Development

B lymphocyte development in the bone marrow proceeds through ordered stages of immunoglobulin gene rearrangement and selection. Pro-B cells initiate heavy chain rearrangement, progressing to pre-B cells upon successful heavy chain expression and pairing with surrogate light chains [13]. Large pre-B cells undergo light chain rearrangement, and successfully rearranged B cells express surface IgM, becoming immature B cells [14].

Central B cell tolerance mechanisms eliminate autoreactive B cells through receptor editing, clonal deletion, or anergy induction. B cells with strong reactivity to self-antigens in the bone marrow undergo apoptosis or receptor editing through secondary light chain rearrangement [15].

Hematopoietic Stem Cell Niche

The bone marrow microenvironment contains specialized niches that regulate hematopoietic stem cell (HSC) maintenance, self-renewal, and differentiation. Perivascular niches, comprising endothelial cells, mesenchymal stromal cells, and CXCL12-abundant reticular (CAR) cells, provide critical signals including stem cell factor (SCF) and CXCL12 that maintain HSC quiescence and support lymphopoiesis [16].

Clinical Correlations

Bone marrow examination remains essential for diagnosing hematologic malignancies, including acute and chronic leukemias, lymphomas with marrow involvement, and plasma cell dyscrasias. Bone marrow failure syndromes such as aplastic anemia result in pancytopenia and immunodeficiency [17].

Secondary Lymphoid Organs #

Lymph Nodes

Lymph nodes are encapsulated structures strategically positioned along lymphatic vessels to filter lymph and facilitate encounters between antigens and lymphocytes. Their specialized architecture creates distinct microenvironments optimized for immune surveillance and adaptive immune responses [18].

Anatomical Organization

Lymph nodes possess a characteristic structure with an outer cortex, paracortex, and inner medulla surrounded by a fibrous capsule. Afferent lymphatic vessels enter through the capsule, draining into the subcapsular sinus, while efferent lymphatics exit at the hilum [19].

The cortex contains B cell-rich lymphoid follicles, which exist as primary follicles in the naive state and transform into secondary follicles with germinal centers following antigenic stimulation. The paracortex represents the T cell-rich zone containing high endothelial venules (HEVs) that facilitate lymphocyte trafficking from blood into lymph nodes [20].

The medulla consists of medullary cords containing plasma cells, macrophages, and antibody-secreting cells, along with medullary sinuses that channel lymph toward the efferent lymphatics [21].

Lymphoid Follicles and Germinal Centers

Primary follicles contain naive B cells and follicular dendritic cells (FDCs) in a network that can capture and retain antigens. Following antigenic stimulation and T cell help, activated B cells proliferate extensively, forming secondary follicles with germinal centers [22].

Germinal centers display characteristic polarization into dark and light zones. The dark zone contains rapidly dividing centroblasts undergoing somatic hypermutation of immunoglobulin variable regions, generating antibody diversity. The light zone contains centrocytes undergoing selection based on affinity for antigen displayed on FDCs, with high-affinity clones receiving survival signals from follicular helper T cells (Tfh) [23].

Somatic hypermutation and class switch recombination, mediated by activation-induced cytidine deaminase (AID), enable antibody affinity maturation and isotype switching, respectively [24]. Germinal centers produce memory B cells and long-lived plasma cells that migrate to the bone marrow and medullary cords [25].

Paracortex and T Cell Zones

The paracortex houses T lymphocytes, dendritic cells, and specialized fibroblastic reticular cells (FRCs) that form a conduit network for antigen delivery to resident dendritic cells. Dendritic cells presenting antigens on MHC molecules interact with T cells, initiating adaptive immune responses [26].

High endothelial venules express adhesion molecules (peripheral node addressin, PNAd) and chemokines (CCL21) that recruit circulating naive lymphocytes expressing L-selectin (CD62L) and CCR7 into lymph nodes [27]. This specialized vasculature enables continuous immune surveillance by facilitating lymphocyte recirculation.

Clinical Correlations

Lymphadenopathy serves as a critical clinical sign indicating infection, autoimmune disease, or malignancy. Reactive lymph node hyperplasia demonstrates follicular hyperplasia with prominent germinal centers in response to antigenic stimulation. Lymphomas preferentially involve lymph nodes, with architecture and immunophenotyping guiding diagnosis and classification [28].

Lymph node metastases represent a major route of cancer dissemination, with sentinel lymph node biopsy used for staging solid tumors including breast cancer and melanoma [29]. Castleman disease demonstrates excessive lymph node enlargement with characteristic histologic patterns [30].

Spleen

The spleen functions as both a secondary lymphoid organ and a site of blood filtration, removing senescent erythrocytes and encapsulated bacteria while orchestrating immune responses to blood-borne antigens [31].

Anatomical Structure

The spleen is the largest secondary lymphoid organ, located in the left upper quadrant and organized into white pulp (lymphoid tissue) and red pulp (vascular filtration tissue). White pulp surrounds central arterioles and contains T cell zones (periarteriolar lymphoid sheaths, PALS) and B cell follicles, while red pulp comprises sinusoids and splenic cords involved in blood filtration [32].

The marginal zone, positioned between white and red pulp, contains specialized marginal zone B cells and macrophages that respond to blood-borne pathogens, particularly encapsulated bacteria [33]. This region plays a critical role in capturing particulate antigens and initiating T-independent antibody responses.

Immune Functions

The spleen filters approximately 5% of cardiac output, allowing continuous immune surveillance of blood-borne antigens. Marginal zone macrophages and B cells recognize polysaccharide antigens and mount rapid IgM responses against encapsulated bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis [34].

Red pulp macrophages remove damaged or opsonized erythrocytes, serving as the primary site of extravascular hemolysis. The spleen also serves as a reservoir for platelets and monocytes [35].

Clinical Correlations

Asplenia, whether anatomical (splenectomy) or functional (sickle cell disease), dramatically increases susceptibility to infections with encapsulated bacteria due to loss of marginal zone function and impaired opsonophagocytosis [36]. Post-splenectomy patients require vaccination against S. pneumoniae, H. influenzae type b, and N. meningitidis, with some requiring antibiotic prophylaxis [37].

Splenomegaly results from numerous etiologies including portal hypertension, hematologic malignancies, hemolytic anemias, and storage diseases. Splenic rupture may occur following blunt abdominal trauma, representing a surgical emergency [38].

Howell-Jolly bodies (nuclear remnants in erythrocytes), target cells, and acanthocytes on peripheral blood smear indicate functional hyposplenism or asplenia, as these abnormal cells are normally removed by splenic macrophages [39].

Mucosa-Associated Lymphoid Tissue (MALT)

Mucosa-associated lymphoid tissue represents the largest component of the lymphoid system, providing immune defense at mucosal surfaces exposed to environmental antigens and commensal organisms [40].

Organizational Principles

MALT includes organized structures such as tonsils, Peyer’s patches, and appendix, along with diffusely distributed lymphocytes and plasma cells throughout mucosal lamina propria. These tissues lack afferent lymphatics but receive antigens directly through specialized epithelial M (microfold) cells that transcytose luminal antigens to underlying lymphoid follicles [41].

Gut-Associated Lymphoid Tissue (GALT)

Peyer’s patches are organized lymphoid follicles located in the ileal submucosa, containing B cell follicles with germinal centers and interfollicular T cell zones. M cells overlying Peyer’s patches sample luminal antigens and deliver them to dendritic cells, initiating mucosal immune responses [42].

The lamina propria throughout the intestinal tract contains abundant IgA-secreting plasma cells. Secretory IgA, produced as dimers and transported across epithelium by the polymeric immunoglobulin receptor, provides immune exclusion of pathogens while maintaining tolerance to commensal bacteria and food antigens [43].

Intraepithelial lymphocytes, predominantly CD8⁺ T cells, reside between intestinal epithelial cells and provide immediate immune responses to epithelial stress or infection [44].

Bronchus-Associated Lymphoid Tissue (BALT)

The respiratory tract contains diffuse lymphoid aggregates and organized bronchus-associated lymphoid tissue that responds to inhaled antigens. While less prominent than GALT in healthy individuals, BALT expands in chronic inflammatory conditions and infections [45].

Waldeyer’s Ring

The pharyngeal, palatine, and lingual tonsils form Waldeyer’s ring, providing immune defense against upper respiratory and oral pathogens. These structures contain crypts lined with stratified squamous epithelium, with underlying lymphoid follicles containing germinal centers [46].

Clinical Correlations

MALT lymphomas arise from chronic antigenic stimulation, with gastric MALT lymphoma frequently associated with Helicobacter pylori infection. Eradication of H. pylori can induce regression of early-stage gastric MALT lymphoma [47].

Selective IgA deficiency, the most common primary immunodeficiency, results in increased susceptibility to mucosal infections and associations with autoimmune disorders and allergies [48]. Chronic tonsillitis may necessitate tonsillectomy, though this procedure may increase risk of later infections due to loss of mucosal immune tissue [49].

Lymphocyte Trafficking and Homing #

Adhesion Molecules and Chemokines

Lymphocyte recirculation through secondary lymphoid organs enables rare antigen-specific lymphocytes to encounter their cognate antigens. This process depends on coordinated expression of adhesion molecules and chemokine receptors [50].

Selectins and Addressins

L-selectin (CD62L) on naive T and B cells binds to peripheral node addressin (PNAd) on high endothelial venules, mediating rolling adhesion. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) on intestinal vessels interacts with α4β7 integrin, directing lymphocytes to gut-associated lymphoid tissue [51].

Integrins

Lymphocyte function-associated antigen-1 (LFA-1, αLβ2 integrin) binds to intercellular adhesion molecule-1 (ICAM-1) on endothelium, enabling firm adhesion following chemokine activation. Very late antigen-4 (VLA-4, α4β1 integrin) mediates adhesion to vascular cell adhesion molecule-1 (VCAM-1) [52].

Leukocyte adhesion deficiency (LAD) results from mutations affecting integrin expression or function, causing recurrent bacterial infections, delayed wound healing, and elevated neutrophil counts due to impaired leukocyte extravasation [53].

Chemokine Receptors

CCR7 expression on naive T cells and central memory T cells directs migration to lymph nodes by responding to CCL19 and CCL21 expressed by fibroblastic reticular cells and high endothelial venules. Effector T cells downregulate CCR7 and upregulate chemokine receptors appropriate for peripheral tissue homing [54].

CXCR5 expression on B cells and follicular helper T cells directs migration into B cell follicles in response to CXCL13 produced by follicular dendritic cells [55].

Sphingosine-1-Phosphate and Lymphocyte Egress

Sphingosine-1-phosphate (S1P) gradients regulate lymphocyte egress from lymphoid organs. S1P receptor 1 (S1PR1) on lymphocytes senses high S1P concentrations in blood and lymph compared to lymphoid tissue, directing egress through efferent lymphatics [56].

Fingolimod (FTY720), used in multiple sclerosis treatment, acts as a functional S1P receptor antagonist, sequestering lymphocytes in lymph nodes and reducing autoimmune central nervous system inflammation [57].

Development and Immune Function #

Lymphoid Organogenesis

Secondary lymphoid organ development requires coordinated interactions between lymphoid tissue inducer (LTi) cells, which are innate lymphoid cells, and lymphoid tissue organizer (LTo) cells, which are mesenchymal stromal cells. LTi cells express lymphotoxin-α1β2, which binds to lymphotoxin-β receptor on LTo cells, initiating stromal cell differentiation and chemokine expression [58].

Mice deficient in lymphotoxin signaling lack lymph nodes and Peyer’s patches, demonstrating the critical role of this pathway in lymphoid organogenesis [59].

Germinal Center Reaction

The germinal center reaction represents the cornerstone of high-affinity antibody production and B cell memory formation. Following T cell-dependent antigenic stimulation, activated B cells migrate into follicles, proliferate extensively, and undergo somatic hypermutation mediated by activation-induced cytidine deaminase (AID) [60].

Centrocytes with high-affinity B cell receptors receive survival signals from follicular helper T cells and follicular dendritic cells, while low-affinity clones undergo apoptosis by neglect. This iterative selection process produces progressively higher-affinity antibodies [61].

Class switch recombination enables B cells to switch from IgM to IgG, IgA, or IgE while maintaining antigen specificity, tailoring effector functions to specific pathogens. Cytokines from T helper cells direct class switching patterns: IFN-γ promotes IgG2a/IgG1 (mouse/human), IL-4 promotes IgE and IgG4, and TGF-β promotes IgA [62].

Hyper-IgM syndrome results from mutations affecting CD40L (X-linked) or AID (autosomal recessive), preventing class switch recombination and resulting in elevated IgM with deficient IgG, IgA, and IgE. Affected individuals experience recurrent pyogenic infections and opportunistic infections including Pneumocystis jirovecii [63].

Lymphoid Structure Pathology #

Lymphomas

Lymphomas arise from malignant transformation of lymphocytes at various developmental stages, with classification based on cell of origin, immunophenotype, genetic alterations, and clinical behavior [64].

Hodgkin Lymphoma

Hodgkin lymphoma is characterized by Reed-Sternberg cells (large multinucleated cells) within a mixed inflammatory background. Reed-Sternberg cells are typically CD15⁺ and CD30⁺ but lack expression of common B cell markers (CD20). Classical Hodgkin lymphoma presents with painless lymphadenopathy, often with mediastinal involvement, and “B symptoms” (fever, night sweats, weight loss) [65].

Non-Hodgkin Lymphomas

Non-Hodgkin lymphomas encompass a diverse group of lymphoid malignancies. Follicular lymphoma, characterized by BCL2 overexpression due to t(14;18) translocation, demonstrates follicular architecture with germinal center B cells. Diffuse large B cell lymphoma, the most common aggressive lymphoma, shows diffuse effacement of nodal architecture by large B cells [66].

Burkitt lymphoma displays a “starry sky” appearance due to tingible body macrophages among sheets of rapidly proliferating B cells, with characteristic MYC translocation t(8;14) [67]. Marginal zone lymphomas include MALT lymphomas arising from chronic antigenic stimulation [68].

Immunodeficiencies Affecting Lymphoid Structure

Severe combined immunodeficiency (SCID) encompasses genetic defects causing profound T and B cell deficiency. X-linked SCID results from mutations in the common gamma chain shared by multiple cytokine receptors (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21), preventing T cell and NK cell development while B cells remain present but nonfunctional [69].

Adenosine deaminase (ADA) deficiency causes accumulation of toxic metabolites particularly affecting lymphocytes, resulting in SCID with characteristic absence of lymphoid tissue including thymic shadow on chest radiograph [70].

Wiskott-Aldrich syndrome, caused by mutations in the WAS gene encoding WASP, presents with immunodeficiency, thrombocytopenia, and eczema. Progressive depletion of lymphocytes occurs, with particular loss of T cells [71].

Clinical Integration #

Lymph Node Biopsy Interpretation

Lymph node architecture assessment is critical for distinguishing reactive hyperplasia from lymphoma. Normal architecture includes preservation of cortex, paracortex, and medulla with intact sinuses. Follicular hyperplasia demonstrates enlarged, irregular germinal centers with tingible body macrophages and preserved mantle zones [72].

Architectural effacement suggests lymphoma, requiring immunophenotyping, flow cytometry, and molecular studies. Pattern recognition (follicular, diffuse, interfollicular) combined with immunohistochemistry guides diagnosis [73].

Imaging of Lymphoid Organs

Computed tomography and positron emission tomography-computed tomography (PET-CT) enable assessment of lymphadenopathy and splenomegaly. Lymph nodes greater than 1 cm in short axis are generally considered enlarged, though normal size varies by anatomic location [74].

FDG-PET imaging demonstrates metabolic activity in lymphoid malignancies, enabling staging, treatment response assessment, and surveillance. Certain lymphomas, particularly indolent types, may show variable FDG avidity [75].

Vaccines and Lymphoid Tissue

Vaccine efficacy depends on effective antigen delivery to secondary lymphoid organs and induction of germinal center responses. Adjuvants enhance immune responses by promoting dendritic cell maturation and migration to draining lymph nodes [76].

Live attenuated vaccines are generally contraindicated in immunocompromised individuals including those with primary immunodeficiencies, HIV infection with severe immunosuppression, or those receiving immunosuppressive therapies, due to risk of vaccine-strain infection [77].

Conclusion #

Lymphoid organs provide the architectural framework essential for adaptive immunity, creating specialized microenvironments that support lymphocyte development, antigen presentation, clonal selection, and immune memory formation. Understanding lymphoid structure illuminates the pathophysiology of immunodeficiencies, autoimmune disorders, and lymphoproliferative diseases while informing clinical assessment and therapeutic interventions. Continued investigation of lymphoid tissue organization, cellular interactions, and molecular regulation will further advance immunology and clinical medicine.

References #

  1. Chaudhry MS, Velardi E, Malard F, van den Brink MRM. Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus. J Immunol. 2017;198(1):40-46. https://doi.org/10.4049/jimmunol.1601100
  2. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6(2):127-135. https://doi.org/10.1038/nri1781
  3. Watanabe N, Wang YH, Lee HK, et al. Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005;436(7054):1181-1185. https://doi.org/10.1038/nature03886
  4. Raviola E, Karnovsky MJ. Evidence for a blood-thymus barrier using electron-opaque tracers. J Exp Med. 1972;136(3):466-498. https://doi.org/10.1084/jem.136.3.466
  5. Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2002;2(5):309-322. https://doi.org/10.1038/nri798
  6. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21:139-176. https://doi.org/10.1146/annurev.immunol.21.120601.141107
  7. Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol. 2014;14(6):377-391. https://doi.org/10.1038/nri3667
  8. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298(5597):1395-1401. https://doi.org/10.1126/science.1075958
  9. Husebye ES, Anderson MS, Kämpe O. Autoimmune polyendocrine syndromes. N Engl J Med. 2018;378(12):1132-1141. https://doi.org/10.1056/NEJMra1713301
  10. McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071. https://doi.org/10.1038/nrdp.2015.71
  11. Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30. https://doi.org/10.1038/s41572-019-0079-y
  12. Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015;15(3):160-171. https://doi.org/10.1038/nri3795
  13. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595-621. https://doi.org/10.1146/annurev.immunol.19.1.595
  14. Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol. 2009;9(3):195-205. https://doi.org/10.1038/nri2491
  15. Nemazee D. Mechanisms of central tolerance for B cells. Nat Rev Immunol. 2017;17(5):281-294. https://doi.org/10.1038/nri.2017.19
  16. Crane GM, Jeffery E, Morrison SJ. Adult haematopoietic stem cell niches. Nat Rev Immunol. 2017;17(9):573-590. https://doi.org/10.1038/nri.2017.53
  17. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509-2519. https://doi.org/10.1182/blood-2006-03-010777
  18. Willard-Mack CL. Normal structure, function, and histology of lymph nodes. Toxicol Pathol. 2006;34(5):409-424. https://doi.org/10.1080/01926230600867727
  19. Junt T, Moseman EA, Iannacone M, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007;450(7166):110-114. https://doi.org/10.1038/nature06287
  20. Girard JP, Moussion C, Förster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 2012;12(11):762-773. https://doi.org/10.1038/nri3298
  21. Katakai T, Hara T, Lee JH, Gonda H, Sugai M, Shimizu A. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol. 2004;16(8):1133-1142. https://doi.org/10.1093/intimm/dxh113
  22. Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol. 2012;30:429-457. https://doi.org/10.1146/annurev-immunol-020711-075032
  23. Allen CDC, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity. 2007;27(2):190-202. https://doi.org/10.1016/j.immuni.2007.07.009
  24. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102(5):553-563. https://doi.org/10.1016/s0092-8674(00)00078-7
  25. Phan TG, Paus D, Chan TD, et al. High affinity germinal center B cells are actively selected into the plasma cell compartment. J Exp Med. 2006;203(11):2419-2424. https://doi.org/10.1084/jem.20061254
  26. Sixt M, Kanazawa N, Selg M, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity. 2005;22(1):19-29. https://doi.org/10.1016/j.immuni.2004.11.013
  27. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 2003;3(11):867-878. https://doi.org/10.1038/nri1222
  28. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon: International Agency for Research on Cancer; 2017.
  29. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927-933. https://doi.org/10.1016/S1470-2045(10)70207-2
  30. van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115-2124. https://doi.org/10.1182/blood-2018-07-862334
  31. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606-616. https://doi.org/10.1038/nri1669
  32. Cesta MF. Normal structure, function, and histology of the spleen. Toxicol Pathol. 2006;34(5):455-465. https://doi.org/10.1080/01926230600867743
  33. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol. 2013;13(2):118-132. https://doi.org/10.1038/nri3383
  34. Zandvoort A, Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol. 2002;130(1):4-11. https://doi.org/10.1046/j.1365-2249.2002.01953.x
  35. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612-616. https://doi.org/10.1126/science.1175202
  36. Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011;378(9785):86-97. https://doi.org/10.1016/S0140-6736(10)61493-6
  37. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44-e100. https://doi.org/10.1093/cid/cit684
  38. Bhangu A, Nepogodiev D, Lal N, et al. Meta-analysis of predictive factors and outcomes for failure of non-operative management of blunt splenic trauma. Injury. 2012;43(9):1337-1346. https://doi.org/10.1016/j.injury.2011.09.010
  39. Corazza GR, Zoli G, Di Sabatino A, Ciccocioppo R, Gasbarrini G. A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol. 1999;94(2):391-397. https://doi.org/10.1111/j.1572-0241.1999.00860.x
  40. Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol. 2008;1(1):31-37. https://doi.org/10.1038/mi.2007.9
  41. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013;6(4):666-677. https://doi.org/10.1038/mi.2013.30
  42. Jung C, Hugot JP, Barreau F. Peyer’s patches: the immune sensors of the intestine. Int J Inflam. 2010;2010:823710. https://doi.org/10.4061/2010/823710
  43. Johansen FE, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol. 2011;4(6):598-602. https://doi.org/10.1038/mi.2011.37
  44. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol. 2011;11(7):445-456. https://doi.org/10.1038/nri3007
  45. Randall TD. Bronchus-associated lymphoid tissue (BALT) structure and function. Adv Immunol. 2010;107:187-241. https://doi.org/10.1016/B978-0-12-381300-8.00007-1
  46. Perry M, Whyte A. Immunology of the tonsils. Immunol Today. 1998;19(9):414-421. https://doi.org/10.1016/s0167-5699(98)01307-3
  47. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342(8871):575-577. https://doi.org/10.1016/0140-6736(93)91409-f
  48. Yel L. Selective IgA deficiency. J Clin Immunol. 2010;30(1):10-16. https://doi.org/10.1007/s10875-009-9357-x
  49. Altwairqi RG, Alnashmi AM, Algazlan SS, Albalawi M. The effect of tonsillectomy on humoral immunity. Cureus. 2020;12(7):e9413. https://doi.org/10.7759/cureus.9413
  50. Steeber DA, Tedder TF. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res. 2000;22(2-3):299-317. https://doi.org/10.1385/IR:22:2-3:299
  51. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004;22:129-156. https://doi.org/10.1146/annurev.immunol.21.090501.080131
  52. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76(2):301-314. https://doi.org/10.1016/0092-8674(94)90337-9
  53. Etzioni A. Genetic etiologies of leukocyte adhesion defects. Curr Opin Immunol. 2009;21(5):481-486. https://doi.org/10.1016/j.coi.2009.07.005
  54. Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8(5):362-371. https://doi.org/10.1038/nri2297
  55. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med. 1999;190(8):1123-1134. https://doi.org/10.1084/jem.190.8.1123
  56. Cyster JG, Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol. 2012;30:69-94. https://doi.org/10.1146/annurev-immunol-020711-075011
  57. Brinkmann V, Billich A, Baumruker T, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9(11):883-897. https://doi.org/10.1038/nrd3248
  58. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol. 2010;10(9):664-674. https://doi.org/10.1038/nri2832
  59. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med. 1996;184(5):1999-2006. https://doi.org/10.1084/jem.184.5.1999
  60. De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol. 2015;15(3):137-148. https://doi.org/10.1038/nri3804
  61. Victora GD, Schwickert TA, Fooksman DR, et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell. 2010;143(4):592-605. https://doi.org/10.1016/j.cell.2010.10.032
  62. Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol. 2008;26:261-292. https://doi.org/10.1146/annurev.immunol.26.021607.090248
  63. Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol. 2000;120(3):399-405. https://doi.org/10.1046/j.1365-2249.2000.01142.x
  64. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390. https://doi.org/10.1182/blood-2016-01-643569
  65. Küppers R, Engert A, Hansmann ML. Hodgkin lymphoma. J Clin Invest. 2012;122(10):3439-3447. https://doi.org/10.1172/JCI61245
  66. Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384(9):842-858. https://doi.org/10.1056/NEJMra2027612
  67. Molyneux EM, Rochford R, Griffin B, et al. Burkitt’s lymphoma. Lancet. 2012;379(9822):1234-1244. https://doi.org/10.1016/S0140-6736(11)61177-X
  68. Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood. 2016;127(17):2082-2092. https://doi.org/10.1182/blood-2015-12-624304
  69. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73(1):147-157. https://doi.org/10.1016/0092-8674(93)90167-o
  70. Hershfield MS. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin Hematol. 1998;35(4):291-298.
  71. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117(4):725-738. https://doi.org/10.1016/j.jaci.2006.02.005
  72. Ioachim HL, Ratech H. Ioachim’s Lymph Node Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
  73. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009:523-531. https://doi.org/10.1182/asheducation-2009.1.523
  74. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-3068. https://doi.org/10.1200/JCO.2013.54.8800
  75. Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058. https://doi.org/10.1200/JCO.2013.53.5229
  76. Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114. https://doi.org/10.3389/fimmu.2013.00114
  77. Kroger AT, Duchin J, Vazquez M. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention; 2021. https://doi.org/10.15585/mmwr.rr7001a1

Updated on December 12, 2025